Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer

  1. Cabezas-Camarero, S.
  2. Merino-Menéndez, S.
  3. Cabrera-Martín, M.N.
  4. Sotelo, M.J.
  5. Plaza-Hernández, J.C.
  6. Falahat, F.
  7. Iglesias-Moreno, M.C.
  8. Pérez-Segura, P.
Revue:
Oncology Letters

ISSN: 1792-1082,  1792-1074

Année de publication: 2023

Volumen: 25

Número: 1

Type: Révision

DOI: 10.3892/OL.2022.13623 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus